» Articles » PMID: 22028311

Cell Autonomous Requirement of Connexin 43 for Osteocyte Survival: Consequences for Endocortical Resorption and Periosteal Bone Formation

Overview
Date 2011 Oct 27
PMID 22028311
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

Connexin 43 (Cx43) mediates osteocyte communication with other cells and with the extracellular milieu and regulates osteoblastic cell signaling and gene expression. We now report that mice lacking Cx43 in osteoblasts/osteocytes or only in osteocytes (Cx43(ΔOt) mice) exhibit increased osteocyte apoptosis, endocortical resorption, and periosteal bone formation, resulting in higher marrow cavity and total tissue areas measured at the femoral mid-diaphysis. Blockade of resorption reversed the increased marrow cavity but not total tissue area, demonstrating that endocortical resorption and periosteal apposition are independently regulated. Anatomical mapping of apoptotic osteocytes, osteocytic protein expression, and resorption and formation suggests that Cx43 controls osteoclast and osteoblast activity by regulating osteoprotegerin and sclerostin levels, respectively, in osteocytes located in specific areas of the cortex. Whereas empty lacunae and living osteocytes lacking osteoprotegerin were distributed throughout cortical bone in Cx43(ΔOt) mice, apoptotic osteocytes were preferentially located in areas containing osteoclasts, suggesting that osteoclast recruitment requires active signaling from dying osteocytes. Furthermore, Cx43 deletion in cultured osteocytic cells resulted in increased apoptosis and decreased osteoprotegerin expression. Thus, Cx43 is essential in a cell-autonomous fashion in vivo and in vitro for osteocyte survival and for controlling the expression of osteocytic genes that affect osteoclast and osteoblast function.

Citing Articles

Regulatory cellular and molecular networks in the bone microenvironment during aging.

Zhang L, Wang Z, Zhang Y, Ji R, Li Z, Zou J Life Med. 2025; 3(3):lnae019.

PMID: 39871887 PMC: 11749081. DOI: 10.1093/lifemedi/lnae019.


Skeletal abnormalities caused by a Connexin43 mutation in a mouse model for autosomal recessive craniometaphyseal dysplasia.

Fujii Y, Okabe I, Hatori A, Sah S, Kanaujiya J, Fisher M Bone Res. 2025; 13(1):14.

PMID: 39848944 PMC: 11757998. DOI: 10.1038/s41413-024-00383-z.


Targeting the mTOR-Autophagy Axis: Unveiling Therapeutic Potentials in Osteoporosis.

Chen R, Yang C, Yang F, Yang A, Xiao H, Peng B Biomolecules. 2024; 14(11).

PMID: 39595628 PMC: 11591800. DOI: 10.3390/biom14111452.


Independent contribution of gonads and sex chromosomes to sex differences in bone mass and strength in the four-core genotypes mouse model.

Ramirez G, Okpara C, Arnett M, Segvich D, Deosthale P, Gonzalez P J Bone Miner Res. 2024; 39(11):1659-1672.

PMID: 39255371 PMC: 11523188. DOI: 10.1093/jbmr/zjae147.


Connexin hemichannels drive lactation-induced osteocyte acidification and perilacunar-canalicular remodeling.

Hua R, Truong V, Fajardo R, Guda T, Gu S, Jiang J Cell Rep. 2024; 43(7):114363.

PMID: 38935505 PMC: 11318086. DOI: 10.1016/j.celrep.2024.114363.


References
1.
Cherian P, Siller-Jackson A, Gu S, Wang X, Bonewald L, Sprague E . Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell. 2005; 16(7):3100-6. PMC: 1165395. DOI: 10.1091/mbc.e04-10-0912. View

2.
Plotkin L, Weinstein R, Parfitt A, Roberson P, Manolagas S, Bellido T . Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999; 104(10):1363-74. PMC: 409837. DOI: 10.1172/JCI6800. View

3.
Paic F, Igwe J, Nori R, Kronenberg M, Franceschetti T, Harrington P . Identification of differentially expressed genes between osteoblasts and osteocytes. Bone. 2009; 45(4):682-92. PMC: 2731004. DOI: 10.1016/j.bone.2009.06.010. View

4.
Parfitt A, Drezner M, Glorieux F, Kanis J, MALLUCHE H, Meunier P . Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2(6):595-610. DOI: 10.1002/jbmr.5650020617. View

5.
Bellido T, Ali A, Gubrij I, Plotkin L, Fu Q, OBrien C . Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. 2005; 146(11):4577-83. DOI: 10.1210/en.2005-0239. View